or Try an Advanced Search...

    Technical Analysis for NGEN - Nervgen Pharma Corp

    Grade Last Price % Change Price Change
    D 2.600 -1.52% -0.040
    NGEN closed down 1.52 percent on Friday, September 6, 2024, on 61 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical NGEN trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -1.52%
    Stochastic Reached Oversold Weakness -1.52%
    Down 3 Days in a Row Weakness -1.52%
    Down 4 Days in a Row Weakness -1.52%
    Oversold Stochastic Weakness -1.52%
    Older End-of-Day Signals for NGEN ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 2 days ago
    Fell Below Previous Day's Low 2 days ago
    10 DMA Resistance 2 days ago
    Outside Day 2 days ago
    Up 3% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    NGEN Chart by TradingView
    Basic chart:

    Profile

    NervGen Pharma Corp. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of nerve damage. Its product candidate is the NVG-291 that is in clinical studies for the treatment of spinal cord injuries (SCI). It has a licensing agreement with Case Western Reserve University of Cleveland, Ohio to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Pharma Pharmaceutical Clinic Pharmaceutical Products

    Is NGEN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 27 NervGen Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 18 Here's Why We're Not At All Concerned With NervGen Pharma's (CVE:NGEN) Cash Burn Situation
    Aug 6 NervGen Pharma to Present at the Canaccord Genuity 44th Annual Growth Conference
    Jun 25 NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage
    Jun 20 NervGen Pharma to Present at the 2nd Annual Spinal Cord Injury Investor Symposium
    Jun 6 NervGen Pharma Grants Stock Options
    Jun 5 NervGen Pharma Announces Results of Annual General Meeting of Shareholders
    May 17 NervGen Pharma to Present Two Posters at the American Spinal Injury Association 51st Annual Scientific Meeting
    May 16 NervGen Pharma Reports Q1 2024 Financial Results and Operational Updates
    May 7 NervGen Files Management Information Circular and Announces Board of Directors Transition
    See more NGEN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.98
    52 Week Low 1.58
    Average Volume 65,897
    200-Day Moving Average 2.518
    50-Day Moving Average 2.874
    20-Day Moving Average 2.808
    10-Day Moving Average 2.720
    Average True Range 0.139
    RSI (14) 40.12
    ADX 27.04
    +DI 26.842
    -DI 18.314
    Chandelier Exit (Long, 3 ATRs) 2.894
    Chandelier Exit (Short, 3 ATRs) 3.016
    Upper Bollinger Bands 3.030
    Lower Bollinger Band 2.585
    Percent B (%b) 0.03
    BandWidth 15.843
    MACD Line -0.048
    MACD Signal Line -0.022
    MACD Histogram -0.0259
    Fundamentals Value
    Market Cap 91.3 Million
    Num Shares 35.1 Million
    EPS -0.30
    Price-to-Earnings (P/E) Ratio -8.64
    Price-to-Sales 0.00
    Price-to-Book 6.30
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.825
    Resistance 3 (R3) 2.850 2.800 2.788
    Resistance 2 (R2) 2.800 2.743 2.788 2.775
    Resistance 1 (R1) 2.700 2.707 2.675 2.675 2.762
    Pivot Point 2.650 2.650 2.638 2.638 2.650
    Support 1 (S1) 2.550 2.593 2.525 2.525 2.438
    Support 2 (S2) 2.500 2.557 2.488 2.425
    Support 3 (S3) 2.400 2.500 2.413
    Support 4 (S4) 2.375